Navigating the Maze of Kinases: CaMK-like Family Protein Kinases and Their Role in Atherosclerosis

Circulating low-density lipoprotein (LDL) levels are a major risk factor for cardiovascular diseases (CVD), and even though current treatment strategies focusing on lowering lipid levels are effective, CVD remains the primary cause of death worldwide. Atherosclerosis is the major cause of CVD and is a chronic inflammatory condition in which various cell types and protein kinases play a crucial role. However, the underlying mechanisms of atherosclerosis are not entirely understood yet. Notably, protein kinases are highly druggable targets and represent, therefore, a novel way to target atherosclerosis. In this review, the potential role of the calcium/calmodulin-dependent protein kinase-like (CaMKL) family and its role in atherosclerosis will be discussed. This family consists of 12 subfamilies, among which are the well-described and conserved liver kinase B1 (LKB1) and 5′ adenosine monophosphate-activated protein kinase (AMPK) subfamilies. Interestingly, LKB1 plays a key role and is considered a master kinase within the CaMKL family. It has been shown that LKB1 signaling leads to atheroprotective effects, while, for example, members of the microtubule affinity-regulating kinase (MARK) subfamily have been described to aggravate atherosclerosis development. These observations highlight the importance of studying kinases and their signaling pathways in atherosclerosis, bringing us a step closer to unraveling the underlying mechanisms of atherosclerosis.

[1]  M. Foretz,et al.  The AMPK-related kinase NUAK1 controls cortical axons branching by locally modulating mitochondrial metabolic functions , 2024, Nature communications.

[2]  I. Hanamura,et al.  ARK5 enhances cell survival associated with mitochondrial morphological dynamics from fusion to fission in human multiple myeloma cells , 2024, Cell death discovery.

[3]  H. Hayashi,et al.  AMPK activators suppress cholesterol accumulation in macrophages via suppression of the mTOR pathway. , 2023, Experimental cell research.

[4]  Tudi Li,et al.  LKB1 delays atherosclerosis by inhibiting phenotypic transformation of vascular smooth muscle cells. , 2023, International journal of cardiology.

[5]  R. Dantzer,et al.  Endothelial activation and fibrotic changes are impeded by laminar flow-induced CHK1-SENP2 activity through mechanisms distinct from endothelial-to-mesenchymal cell transition , 2023, Frontiers in cardiovascular medicine.

[6]  D. Drewry,et al.  How many kinases are druggable? A review of our current understanding , 2023, The Biochemical journal.

[7]  Yue Wu,et al.  Smooth muscle liver kinase B1 inhibits foam cell formation and atherosclerosis via direct phosphorylation and activation of SIRT6 , 2023, Cell death & disease.

[8]  Saleha Anwar,et al.  Synthesis, Structural Modification, and Bioactivity Evaluation of Substituted Acridones as Potent Microtubule Affinity-Regulating Kinase 4 Inhibitors. , 2023, ACS pharmacology & translational science.

[9]  R. Roskoski Small molecule protein kinase inhibitors approved by regulatory agencies outside of the United States , 2023, Pharmacological Research.

[10]  H. Jo,et al.  Flow-induced reprogramming of endothelial cells in atherosclerosis , 2023, Nature Reviews Cardiology.

[11]  Sheyu Li,et al.  Chloroquine Alleviates Atherosclerosis by Modulating Regulatory T Cells Through the ATM/AMPK/mTOR Signaling Pathway in ApoE −/− Mice , 2023, Experimental and Clinical Endocrinology & Diabetes.

[12]  Shaoyi Zheng,et al.  Macrophage polarization states in atherosclerosis , 2023, Frontiers in Immunology.

[13]  B. Viollet,et al.  Metformin: update on mechanisms of action and repurposing potential , 2023, Nature Reviews Endocrinology.

[14]  R. Plummer,et al.  A Phase 1/2 trial of SRA737 (a Chk1 inhibitor) administered orally in patients with advanced cancer , 2023, British Journal of Cancer.

[15]  Ana C. Henriques,et al.  SARS-CoV-2 infection induces DNA damage, through CHK1 degradation and impaired 53BP1 recruitment, and cellular senescence , 2023, Nature Cell Biology.

[16]  D. Grobbee,et al.  Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients. , 2023, The New England journal of medicine.

[17]  Jared L. Johnson,et al.  An atlas of substrate specificities for the human serine/threonine kinome , 2023, Nature.

[18]  Matthew David Mulholland,et al.  LAG3 Regulates T Cell Activation and Plaque Infiltration in Atherosclerotic Mice , 2022, JACC. CardioOncology.

[19]  P. Lei,et al.  Mammalian Sterile 20-Like Kinase 1 Suppresses Atherosclerosis. , 2022, Circulation research.

[20]  I. Vergote,et al.  A Phase 2 study of prexasertib (LY2606368) in platinum resistant or refractory recurrent ovarian cancer. , 2022, Gynecologic oncology.

[21]  Yang Zhou,et al.  Metformin suppresses foam cell formation, inflammation and ferroptosis via the AMPK/ERK signaling pathway in ox‑LDL‑induced THP‑1 monocytes , 2022, Experimental and therapeutic medicine.

[22]  R. Bast,et al.  GRN300–001: Phase 1/1B evaluation of the safety, pharmacokinetics, and efficacy of GRN-300, a salt-inducible kinase inhibitor, alone and in combination with paclitaxel, in recurrent ovarian, primary peritoneal, and fallopian tube cancers. , 2022, Journal of Clinical Oncology.

[23]  T. Hunter A journey from phosphotyrosine to phosphohistidine and beyond. , 2022, Molecular cell.

[24]  Peng Kong,et al.  Inflammation and atherosclerosis: signaling pathways and therapeutic intervention , 2022, Signal Transduction and Targeted Therapy.

[25]  Mingming Sun,et al.  GPR65 promotes intestinal mucosal Th1 and Th17 cell differentiation and gut inflammation through downregulating NUAK2 , 2022, Clinical and translational medicine.

[26]  G. Schernthaner,et al.  Metformin and the heart: Update on mechanisms of cardiovascular protection with special reference to comorbid type 2 diabetes and heart failure. , 2022, Metabolism: clinical and experimental.

[27]  W. Wahli,et al.  Adipose-Specific PPARα Knockout Mice Have Increased Lipogenesis by PASK–SREBP1 Signaling and a Polarity Shift to Inflammatory Macrophages in White Adipose Tissue , 2021, Cells.

[28]  G. Dimattia,et al.  Loss of LKB1-NUAK1 signalling enhances NF-κB activity in a spheroid model of high-grade serous ovarian cancer , 2021, Scientific Reports.

[29]  J. Hou,et al.  Metformin inhibits cholesterol-induced adhesion molecule expression via activating the AMPK signaling pathway in vascular smooth muscle cells , 2021, Molecular medicine reports.

[30]  Chao-ke Tang,et al.  Microtubule affinity regulating kinase 4: A promising target in the pathogenesis of atherosclerosis , 2021, Journal of cellular physiology.

[31]  S. Matoba,et al.  Cellular senescence promotes endothelial activation through epigenetic alteration, and consequently accelerates atherosclerosis , 2021, Scientific Reports.

[32]  J. L. de la Pompa,et al.  Fibrous Caps in Atherosclerosis Form by Notch-Dependent Mechanisms Common to Arterial Media Development , 2021, Arteriosclerosis, thrombosis, and vascular biology.

[33]  J. Ji,et al.  Pharmacological inhibition of MELK restricts ferroptosis and the inflammatory response in colitis and colitis-propelled carcinogenesis. , 2021, Free radical biology & medicine.

[34]  Jae-Hoon Chang,et al.  LKB1-PTEN axis controls Th1 and Th17 cell differentiation via regulating mTORC1 , 2021, Journal of Molecular Medicine.

[35]  Q. Jiang,et al.  Role of ARK5 in cancer and other diseases (Review) , 2021, Experimental and therapeutic medicine.

[36]  Yufen Zhao,et al.  Protein arginine phosphorylation in organisms. , 2021, International journal of biological macromolecules.

[37]  Jiliang Wu,et al.  Liver kinase B1 inhibits smooth muscle calcification via high mobility group box 1 , 2020, Redox biology.

[38]  Derek J. Essegian,et al.  The Clinical Kinase Index: A Method to Prioritize Understudied Kinases as Drug Targets for the Treatment of Cancer , 2020, Cell reports. Medicine.

[39]  B. Viollet,et al.  Myeloid deletion and therapeutic activation of AMPK do not alter atherosclerosis in male or female mice , 2020, Journal of Lipid Research.

[40]  Z. Chao,et al.  The phosphorylation of CHK1 at Ser345 regulates the phenotypic switching of vascular smooth muscle cells both in vitro and in vivo. , 2020, Atherosclerosis.

[41]  E. Latz,et al.  Cholesterol crystals use complement to increase NLRP3 signaling pathways in coronary and carotid atherosclerosis , 2020, EBioMedicine.

[42]  Hui Xu,et al.  LKB1‐MARK2 signalling mediates lipopolysaccharide‐induced production of cytokines in mouse macrophages , 2020, Journal of cellular and molecular medicine.

[43]  Q. Cui,et al.  CD4+ T-Cell Endogenous Cystathionine γ Lyase–Hydrogen Sulfide Attenuates Hypertension by Sulfhydrating Liver Kinase B1 to Promote T Regulatory Cell Differentiation and Proliferation , 2020, Circulation.

[44]  Bo Yu,et al.  Colchicine Alleviates Cholesterol Crystal-Induced Endothelial Cell Pyroptosis through Activating AMPK/SIRT1 Pathway , 2020, Oxidative medicine and cellular longevity.

[45]  A. F. Castro,et al.  Cytosolic NUAK1 Enhances ATP Production by Maintaining Proper Glycolysis and Mitochondrial Function in Cancer Cells , 2020, Frontiers in Oncology.

[46]  K. Moore,et al.  Regulatory T Cells License Macrophage Pro-Resolving Functions During Atherosclerosis Regression , 2020, Circulation research.

[47]  Zhi-guang Zhang,et al.  Suberoylanilide Hydroxamic Acid Attenuates Interleukin-1β-Induced Interleukin-6 Upregulation by Inhibiting the Microtubule Affinity-Regulating Kinase 4/Nuclear Factor-κB Pathway in Synovium-Derived Mesenchymal Stem Cells from the Temporomandibular Joint , 2020, Inflammation.

[48]  Nicole M. Chapman,et al.  Signaling networks in immunometabolism , 2020, Cell Research.

[49]  Sheng-Cai Lin,et al.  AMPK and TOR: The Yin and Yang of Cellular Nutrient Sensing and Growth Control. , 2020, Cell metabolism.

[50]  M. Zou,et al.  Cardiomyocyte‐Specific Snrk Prevents Inflammation in the Heart , 2019, Journal of the American Heart Association.

[51]  P. Libby,et al.  Atherosclerosis , 2019, Nature Reviews Disease Primers.

[52]  G. Zhong,et al.  Tim-4 Inhibits NLRP3 Inflammasome via the LKB1/AMPKα Pathway in Macrophages , 2019, The Journal of Immunology.

[53]  Simin Liu,et al.  Dysregulation of PP2A-Akt interaction contributes to Sucrose non-fermenting related kinase (SNRK) deficiency induced insulin resistance in adipose tissue , 2019, Molecular metabolism.

[54]  T. Sun,et al.  LncRNA DYNLRB2-2 inhibits THP-1 macrophage foam cell formation by enhancing autophagy , 2019, Biological chemistry.

[55]  M. Bennett,et al.  Vascular smooth muscle cells in atherosclerosis , 2019, Nature Reviews Cardiology.

[56]  M. Clément,et al.  MARK4 (Microtubule Affinity-Regulating Kinase 4)-Dependent Inflammasome Activation Promotes Atherosclerosis. , 2019, Arteriosclerosis, thrombosis, and vascular biology.

[57]  A. Waisman,et al.  Activation of Mevalonate Pathway via LKB1 Is Essential for Stability of Treg Cells. , 2019, Cell reports.

[58]  Lei Zhang,et al.  Metformin reduced NLRP3 inflammasome activity in Ox‐LDL stimulated macrophages through adenosine monophosphate activated protein kinase and protein phosphatase 2A , 2019, European journal of pharmacology.

[59]  O. Soehnlein,et al.  Myeloid-Specific Deletion of the AMPKα2 Subunit Alters Monocyte Protein Expression and Atherogenesis , 2019, International journal of molecular sciences.

[60]  Ye Ding,et al.  Circulating miR-103a-3p contributes to angiotensin II-induced renal inflammation and fibrosis via a SNRK/NF-κB/p65 regulatory axis , 2019, Nature Communications.

[61]  S. Allahverdian,et al.  Smooth Muscle Cells Contribute the Majority of Foam Cells in ApoE (Apolipoprotein E)-Deficient Mouse Atherosclerosis , 2019, Arteriosclerosis, thrombosis, and vascular biology.

[62]  B. Moran,et al.  Differential Regulation of Human Treg and Th17 Cells by Fatty Acid Synthesis and Glycolysis , 2019, Front. Immunol..

[63]  Peng Xu,et al.  Conditional GWAS revealing genetic impacts of lifestyle behaviors on low-density lipoprotein (LDL) , 2019, Comput. Biol. Chem..

[64]  Chunxiang Zhang,et al.  PRKAA1/AMPKα1-driven glycolysis in endothelial cells exposed to disturbed flow protects against atherosclerosis , 2018, Nature Communications.

[65]  Jeremy D. Woods,et al.  The PTH/PTHrP-SIK3 pathway affects skeletogenesis through altered mTOR signaling , 2018, Science Translational Medicine.

[66]  Hyun-A Seong,et al.  Smad proteins differentially regulate obesity-induced glucose and lipid abnormalities and inflammation via class-specific control of AMPK-related kinase MPK38/MELK activity , 2018, Cell Death & Disease.

[67]  Yun Zhang,et al.  AMPKα inactivation destabilizes atherosclerotic plaque in streptozotocin-induced diabetic mice through AP-2α/miRNA-124 axis , 2018, Journal of Molecular Medicine.

[68]  Yaohui Nie,et al.  Sucrose Nonfermenting-Related Kinase Regulates Both Adipose Inflammation and Energy Homeostasis in Mice and Humans , 2018, Diabetes.

[69]  J. Jeng,et al.  Lysophosphatidylcholine induces cytotoxicity/apoptosis and IL-8 production of human endothelial cells: Related mechanisms , 2017, Oncotarget.

[70]  Yuehua Wu,et al.  Pioglitazone stabilizes atherosclerotic plaque by regulating the Th17/Treg balance in AMPK-dependent mechanisms , 2017, Cardiovascular Diabetology.

[71]  Huaiping Zhu,et al.  Macrophage Liver Kinase B1 Inhibits Foam Cell Formation and Atherosclerosis , 2017, Circulation research.

[72]  W. Xue,et al.  NLRP3 Phosphorylation Is an Essential Priming Event for Inflammasome Activation. , 2017, Molecular cell.

[73]  E. Ma,et al.  AMPK Maintains Cellular Metabolic Homeostasis through Regulation of Mitochondrial Reactive Oxygen Species. , 2017, Cell reports.

[74]  W. Guo,et al.  Lkb1 maintains Treg cell lineage identity , 2017, Nature Communications.

[75]  W. Liu,et al.  C1q/TNF‐related protein 9 inhibits the cholesterol‐induced Vascular smooth muscle cell phenotype switch and cell dysfunction by activating AMP‐dependent kinase , 2017, Journal of cellular and molecular medicine.

[76]  Miao Zhang,et al.  AMP-activated protein kinase α1 promotes atherogenesis by increasing monocyte-to-macrophage differentiation , 2017, The Journal of Biological Chemistry.

[77]  L. Birnbaumer,et al.  Reduced Necrosis and Content of Apoptotic M1 Macrophages in Advanced Atherosclerotic Plaques of Mice With Macrophage-Specific Loss of Trpc3 , 2017, Scientific Reports.

[78]  Hao Wu,et al.  Eating the Dead to Keep Atherosclerosis at Bay , 2017, Front. Cardiovasc. Med..

[79]  D. Greaves,et al.  Tracking Monocyte Recruitment and Macrophage Accumulation in Atherosclerotic Plaque Progression Using a Novel hCD68GFP/ApoE−/− Reporter Mouse—Brief Report , 2017, Arteriosclerosis, thrombosis, and vascular biology.

[80]  Dongling Yang,et al.  Macrophagic CD146 promotes foam cell formation and retention during atherosclerosis , 2017, Cell Research.

[81]  J. Arthur,et al.  Inhibition of SIK2 and SIK3 during differentiation enhances the anti-inflammatory phenotype of macrophages , 2016, The Biochemical journal.

[82]  J. Jeng,et al.  7-Ketocholesterol induces ATM/ATR, Chk1/Chk2, PI3K/Akt signalings, cytotoxicity and IL-8 production in endothelial cells , 2016, Oncotarget.

[83]  Haibo Zhu,et al.  AMP-activated protein kinase attenuates oxLDL uptake in macrophages through PP2A/NF-κB/LOX-1 pathway. , 2016, Vascular pharmacology.

[84]  Sheng-nan Wu,et al.  Ablation of Adenosine Monophosphate-Activated Protein Kinase α1 in Vascular Smooth Muscle Cells Promotes Diet-Induced Atherosclerotic Calcification In Vivo. , 2016, Circulation research.

[85]  Miao Zhang,et al.  AMP-Activated Protein Kinase Alpha 2 Deletion Induces VSMC Phenotypic Switching and Reduces Features of Atherosclerotic Plaque Stability. , 2016, Circulation research.

[86]  A. Ramne,et al.  Cell type-specific deletion in mice reveals roles for PAS kinase in insulin and glucagon production , 2016, Diabetologia.

[87]  C. Gilliéron,et al.  SIK inhibition in human myeloid cells modulates TLR and IL‐1R signaling and induces an anti‐inflammatory phenotype , 2016, Journal of leukocyte biology.

[88]  L. Gan,et al.  Mark4 promotes oxidative stress and inflammation via binding to PPARγ and activating NF-κB pathway in mice adipocytes , 2016, Scientific Reports.

[89]  B. Xue,et al.  Myeloid Deletion of α1AMPK Exacerbates Atherosclerosis in LDL Receptor Knockout (LDLRKO) Mice , 2016, Diabetes.

[90]  P. Loke,et al.  MicroRNA-33-dependent regulation of macrophage metabolism directs immune cell polarization in atherosclerosis. , 2015, The Journal of clinical investigation.

[91]  Cheng-Yi Kuo,et al.  Activation of AMP-Activated Protein Kinase by Adenine Alleviates TNF-Alpha-Induced Inflammation in Human Umbilical Vein Endothelial Cells , 2015, PloS one.

[92]  Y. Liu,et al.  Nuciferine downregulates Per-Arnt-Sim kinase expression during its alleviation of lipogenesis and inflammation on oleic acid-induced hepatic steatosis in HepG2 cells , 2015, Front. Pharmacol..

[93]  L. Addadi,et al.  ABCA1 contributes to macrophage deposition of extracellular cholesterol , 2015, Journal of Lipid Research.

[94]  Laura S. Shankman,et al.  KLF4 Dependent Phenotypic Modulation of SMCs Plays a Key Role in Atherosclerotic Plaque Pathogenesis , 2015, Nature Medicine.

[95]  E. Tuzcu,et al.  Cholesterol crystals associate with coronary plaque vulnerability in vivo. , 2015, Journal of the American College of Cardiology.

[96]  Miao Zhang,et al.  Liver Kinase B1 Suppresses Lipopolysaccharide-induced Nuclear Factor κB (NF-κB) Activation in Macrophages* , 2014, The Journal of Biological Chemistry.

[97]  L. Gan,et al.  Mark4 promotes adipogenesis and triggers apoptosis in 3T3‐L1 adipocytes by activating JNK1 and inhibiting p38MAPK pathways , 2014, Biology of the cell.

[98]  Daniel J. O'Connell,et al.  Small-molecule screening identifies inhibition of salt-inducible kinases as a therapeutic strategy to enhance immunoregulatory functions of dendritic cells , 2014, Proceedings of the National Academy of Sciences.

[99]  Shan Yan,et al.  Functional interplay between ATM/ATR-mediated DNA damage response and DNA repair pathways in oxidative stress , 2014, Cellular and Molecular Life Sciences.

[100]  Dean Sheppard,et al.  TGF-β activation and function in immunity. , 2014, Annual review of immunology.

[101]  I. Rozenberg,et al.  Endothelial overexpression of LOX-1 increases plaque formation and promotes atherosclerosis in vivo. , 2014, European heart journal.

[102]  Kwok-Kin Wong,et al.  A genetic screen identifies an LKB1–MARK signalling axis controlling the Hippo–YAP pathway , 2013, Nature Cell Biology.

[103]  B. Viollet,et al.  AMPKα1 deficiency amplifies proinflammatory myeloid APC activity and CD40 signaling , 2013, Journal of leukocyte biology.

[104]  G. Rao,et al.  The Transcription Factor CREB Enhances Interleukin-17A Production and Inflammation in a Mouse Model of Atherosclerosis , 2013, Science Signaling.

[105]  R. Lister,et al.  ETC-1002 regulates immune response, leukocyte homing, and adipose tissue inflammation via LKB1-dependent activation of macrophage AMPK , 2013, Journal of Lipid Research.

[106]  Yaohui Nie,et al.  Identification of Sucrose Non-Fermenting–Related Kinase (SNRK) as a Suppressor of Adipocyte Inflammation , 2013, Diabetes.

[107]  J. Dąbek,et al.  Transcription activity of MMP-2 and MMP-9 metalloproteinase genes and their tissue inhibitor (TIMP-2) in acute coronary syndrome patients. , 2013, Journal of postgraduate medicine.

[108]  D. Hardie,et al.  Metabolism of inflammation limited by AMPK and pseudo-starvation , 2013, Nature.

[109]  M. McDevitt,et al.  Phase I and Pharmacologic Trial of Cytosine Arabinoside with the Selective Checkpoint 1 Inhibitor Sch 900776 in Refractory Acute Leukemias , 2012, Clinical Cancer Research.

[110]  J. Sznajder,et al.  Salt‐inducible kinase 1 regulates E‐cadherin expression and intercellular junction stability , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[111]  C. Heldin,et al.  Transcriptional Induction of Salt-inducible Kinase 1 by Transforming Growth Factor β Leads to Negative Regulation of Type I Receptor Signaling in Cooperation with the Smurf2 Ubiquitin Ligase* , 2012, The Journal of Biological Chemistry.

[112]  D. Poulikakos,et al.  Phosphorylation of VE-cadherin is modulated by haemodynamic forces and contributes to the regulation of vascular permeability in vivo , 2012, Nature Communications.

[113]  Yuan Zhang,et al.  AMP-Activated Protein Kinase Suppresses Endothelial Cell Inflammation Through Phosphorylation of Transcriptional Coactivator p300 , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[114]  G. Rutter,et al.  Human Mutation within Per-Arnt-Sim (PAS) Domain-containing Protein Kinase (PASK) Causes Basal Insulin Hypersecretion , 2011, The Journal of Biological Chemistry.

[115]  Zuyi Yuan,et al.  Activation of Th17/Th1 and Th1, but not Th17, is associated with the acute cardiac event in patients with acute coronary syndrome. , 2011, Atherosclerosis.

[116]  L. Yi,et al.  Transcriptional regulation of Foxp3 in regulatory T cells. , 2011, Immunobiology.

[117]  S. Girardin,et al.  Mitochondrial ROS fuel the inflammasome , 2011, Cell Research.

[118]  J. Rathmell,et al.  Cutting Edge: Distinct Glycolytic and Lipid Oxidative Metabolic Programs Are Essential for Effector and Regulatory CD4+ T Cell Subsets , 2011, The Journal of Immunology.

[119]  Soo-Ho Choi,et al.  Oxidation-Specific Epitopes Are Danger-Associated Molecular Patterns Recognized by Pattern Recognition Receptors of Innate Immunity , 2011, Circulation research.

[120]  E. Mandelkow,et al.  Structure and function of polarity‐inducing kinase family MARK/Par‐1 within the branch of AMPK/Snf1‐related kinases , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[121]  K. Moore,et al.  NLRP3 inflamasomes are required for atherogenesis and activated by cholesterol crystals that form early in disease , 2010, Nature.

[122]  H. Choi,et al.  Reduction of AMP-Activated Protein Kinase &agr;2 Increases Endoplasmic Reticulum Stress and Atherosclerosis In Vivo , 2010, Circulation.

[123]  Axel Weber,et al.  Interleukin-1 (IL-1) Pathway , 2010, Science Signaling.

[124]  T. Asano,et al.  Activation of AMP-activated Protein Kinase Suppresses Oxidized Low-density Lipoprotein-induced Macrophage Proliferation* , 2009, The Journal of Biological Chemistry.

[125]  R. Shaw,et al.  The LKB1–AMPK pathway: metabolism and growth control in tumour suppression , 2009, Nature Reviews Cancer.

[126]  D. Teupser,et al.  Prevention of atherosclerosis by the mTOR inhibitor everolimus in LDLR-/- mice despite severe hypercholesterolemia. , 2008, Atherosclerosis.

[127]  J. Yates,et al.  Insulin modulates gluconeogenesis by inhibition of the coactivator TORC2. , 2007, Nature.

[128]  P. Teeling,et al.  Low Numbers of FOXP3 Positive Regulatory T Cells Are Present in all Developmental Stages of Human Atherosclerotic Lesions , 2007, PloS one.

[129]  M. Okamoto,et al.  TORC‐SIK cascade regulates CREB activity through the basic leucine zipper domain , 2007, The FEBS journal.

[130]  J. Mehta,et al.  Deletion of LOX-1 Reduces Atherogenesis in LDLR Knockout Mice Fed High Cholesterol Diet , 2007, Circulation research.

[131]  G. Fantuzzi,et al.  Adipose Tissue and Atherosclerosis: Exploring the Connection , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[132]  M. Bennett,et al.  DNA damage and repair in atherosclerosis. , 2006, Cardiovascular research.

[133]  Melanie Lukasser,et al.  Atherosclerosis research from past to present—on the track of two pathologists with opposing views, Carl von Rokitansky and Rudolf Virchow , 2006, Virchows Archiv.

[134]  E. Raines,et al.  Macrophage expression of active MMP-9 induces acute plaque disruption in apoE-deficient mice. , 2005, The Journal of clinical investigation.

[135]  M. Bollen,et al.  Substrate Specificity and Activity Regulation of Protein Kinase MELK* , 2005, Journal of Biological Chemistry.

[136]  David P. Davis,et al.  Maternal embryonic leucine zipper kinase/murine protein serine-threonine kinase 38 is a promising therapeutic target for multiple cancers. , 2005, Cancer research.

[137]  D. Alessi,et al.  Identification of the sucrose non‐fermenting related kinase SNRK, as a novel LKB1 substrate , 2005, FEBS letters.

[138]  R. DePinho,et al.  The LKB1 tumor suppressor negatively regulates mTOR signaling. , 2004, Cancer cell.

[139]  M. Bollen,et al.  Inhibition of Spliceosome Assembly by the Cell Cycle-regulated Protein Kinase MELK and Involvement of Splicing Factor NIPP1* , 2004, Journal of Biological Chemistry.

[140]  Jérôme Boudeau,et al.  LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR‐1 , 2004, The EMBO journal.

[141]  B. Kemp Faculty Opinions recommendation of Complexes between the LKB1 tumor suppressor, STRAD alpha/beta and MO25 alpha/beta are upstream kinases in the AMP-activated protein kinase cascade. , 2003 .

[142]  T. Hunter,et al.  The Protein Kinase Complement of the Human Genome , 2002, Science.

[143]  J. Mehta,et al.  Statins Modulate Oxidized Low-Density Lipoprotein-Mediated Adhesion Molecule Expression in Human Coronary Artery Endothelial Cells: Role of LOX-1 , 2002, Journal of Pharmacology and Experimental Therapeutics.

[144]  F. Martinon,et al.  The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. , 2002, Molecular cell.

[145]  Joseph L Goldstein,et al.  SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. , 2002, The Journal of clinical investigation.

[146]  P. Cohen,et al.  The origins of protein phosphorylation , 2002, Nature Cell Biology.

[147]  K. Alitalo,et al.  Vascular Abnormalities and Deregulation of VEGF in Lkb1-Deficient Mice , 2001, Science.

[148]  G. D. De Meyer,et al.  Oxidative DNA Damage and Repair in Experimental Atherosclerosis Are Reversed by Dietary Lipid Lowering , 2001, Circulation research.

[149]  Y. A. Minamishima,et al.  Aberrant cell cycle checkpoint function and early embryonic death in Chk1(-/-) mice. , 2000, Genes & development.

[150]  K. Williams,et al.  Atherosclerosis--an inflammatory disease. , 1999, The New England journal of medicine.

[151]  B. Kemp,et al.  Non-catalytic - and -Subunit Isoforms of the 5′-AMP-activated Protein Kinase (*) , 1996, The Journal of Biological Chemistry.

[152]  T. Hunter,et al.  The eukaryotic protein kinase superfamily: kinase (catalytic) domain structure and classification 1 , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[153]  R. Wootton,et al.  Selective retention of VLDL, IDL, and LDL in the arterial intima of genetically hyperlipidemic rabbits in vivo. Molecular size as a determinant of fractional loss from the intima-inner media. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[154]  R. Dean,et al.  The intracellular storage and turnover of apolipoprotein B of oxidized LDL in macrophages. , 1992, Biochimica et biophysica acta.

[155]  P. Libby,et al.  Cytokines and growth factors positively and negatively regulate interstitial collagen gene expression in human vascular smooth muscle cells. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

[156]  U. Steinbrecher,et al.  Oxidized low density lipoprotein is resistant to cathepsins and accumulates within macrophages. , 1991, The Journal of biological chemistry.

[157]  J L Witztum,et al.  Lipoproteins and atherogenesis. Current concepts. , 1990, JAMA.

[158]  F. Parhami,et al.  Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[159]  T. Carew,et al.  Initiation of atherosclerotic lesions in cholesterol-fed rabbits. II. Selective retention of LDL vs. selective increases in LDL permeability in susceptible sites of arteries. , 1989, Arteriosclerosis.

[160]  Manning Feinleib,et al.  Obesity as an Independent Risk Factor for Cardiovascular Disease: A 26‐year Follow‐up of Participants in the Framingham Heart Study , 1983, Circulation.

[161]  F. Rovelli [The European Society of Cardiology]. , 1978, Giornale italiano di cardiologia.

[162]  R. Schroter,et al.  Arterial Wall Shear and Distribution of Early Atheroma in Man , 1969, Nature.

[163]  A. Orekhov,et al.  CD68/macrosialin: not just a histochemical marker , 2017, Laboratory Investigation.

[164]  C. Gleissner,et al.  Expression of IL-17A in human atherosclerotic lesions is associated with increased inflammation and plaque vulnerability , 2010, Basic Research in Cardiology.

[165]  Richard J. Shaw Inaugural Article: The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress , 2004 .

[166]  Bruce Alberts,et al.  General Principles of Cell Communication , 2002 .

[167]  T. Hunter,et al.  Protein kinase classification. , 1991, Methods in enzymology.

[168]  BHF Fundraising,et al.  The British Heart Foundation , 1963, Nature.